KDR and osteosarcoma: Angiogenic pathways—for example, vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor (PDGF)—have been implicated in osteosarcoma tumor evolution and linked with their metastatic behavior and poor prognosis.